ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
3,962
Screening encounters
4,681
Diagnostic referrals
898
Outstanding pathways
320

Screening pathway

  1. Screening4,681Encounters
  2. Positive finding1,615Documented findings
  3. Referral898Diagnostic referrals
  4. Follow-up1,070Diagnostic visits
  5. Outcome578Resolved pathways

Stage totals use different units. Pending pathways: 320. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 0465 · EXP-0465Synthetic · Site C

Full participant history through 2026-12-12, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2026-08-22
  4. · Diagnostic referral · EXP-0465-T-R
  5. · Contact attempt · Reached
  6. · Barrier documented · Contact difficulty
  7. · Diagnostic booking · Initial booking
  8. · Navigation intervention · Coordination support
  9. · Diagnostic visit · Missed
  10. · Diagnostic booking · Rebooking
  11. · Diagnostic visit · Attended
  12. · Diagnosis · Colposcopy · Biopsy collected
  13. · Diagnosis · Histopathology · No high-grade lesion identified
  14. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2027-06-09
  15. · Follow-up disposition · Resolved · EXP-0465-T-R

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Unresolved

Screened participants

3962 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-0148 · Expanded synthetic participant 0148Site C — Rural Outreach Programme
EXP-0149 · Expanded synthetic participant 0149Site A — Urban Referral Hub
EXP-0150 · Expanded synthetic participant 0150Site E — Resource-Constrained Navigation Programme
EXP-0151 · Expanded synthetic participant 0151Site D — Community Engagement Programme
EXP-0154 · Expanded synthetic participant 0154Site B — Peri-Urban Access Programme
EXP-0155 · Expanded synthetic participant 0155Site E — Resource-Constrained Navigation Programme
EXP-0156 · Expanded synthetic participant 0156Site A — Urban Referral Hub
EXP-0157 · Expanded synthetic participant 0157Site A — Urban Referral Hub
EXP-0158 · Expanded synthetic participant 0158Site B — Peri-Urban Access Programme
EXP-0159 · Expanded synthetic participant 0159Site D — Community Engagement Programme
EXP-0160 · Expanded synthetic participant 0160Site B — Peri-Urban Access Programme
EXP-0161 · Expanded synthetic participant 0161Site E — Resource-Constrained Navigation Programme
EXP-0163 · Expanded synthetic participant 0163Site C — Rural Outreach Programme
EXP-0164 · Expanded synthetic participant 0164Site C — Rural Outreach Programme
EXP-0165 · Expanded synthetic participant 0165Site D — Community Engagement Programme
EXP-0166 · Expanded synthetic participant 0166Site D — Community Engagement Programme
EXP-0167 · Expanded synthetic participant 0167Site C — Rural Outreach Programme
EXP-0169 · Expanded synthetic participant 0169Site A — Urban Referral Hub
EXP-0170 · Expanded synthetic participant 0170Site A — Urban Referral Hub
EXP-0171 · Expanded synthetic participant 0171Site C — Rural Outreach Programme
EXP-0172 · Expanded synthetic participant 0172Site C — Rural Outreach Programme
EXP-0173 · Expanded synthetic participant 0173Site B — Peri-Urban Access Programme
EXP-0175 · Expanded synthetic participant 0175Site B — Peri-Urban Access Programme
EXP-0176 · Expanded synthetic participant 0176Site A — Urban Referral Hub
EXP-0179 · Expanded synthetic participant 0179Site D — Community Engagement Programme

Programme insights

Encounters by modality

VIA
1784
HPV DNA
2235
Cytology
662

Navigation activity

Barrier documented
798
Contact attempt
1313
Navigation intervention
341
Diagnostic booking
1119
Diagnostic visit
1070

Documented barriers

Contact difficulty
256
Transport difficulty
262
Appointment coordination
280

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.